Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/10/2019
SIETES contiene 92822 citas

 
 
 1 a 20 de 70 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Wei L, Lai EC-C, Kao-Yang Y-H, Walker BR, MacDonald TM, Andrew R. Incidence of type 2 diabetes mellitus in men receiving steroid 5a-reductase inhibitors: population based cohort study. BMJ 2019;365:10 de abril. [Ref.ID 103112]
2. Cita con resumen
Wei L, Ratnayake L, Phillips G, McGuigan CC, Morant SV, Flynn RW, Mackenzie IS, MacDonald TM. Acid-suppression medications and bacterial gastroenteritis: a population-based cohort study. Br J Clin Pharmacol 2017;83:1298-308. [Ref.ID 101942]
3. Cita con resumen
Mackenzie IS, Morant SV, Wei L, Thompson AM, MacDonald TM. Spironolactone use and risk of incident cancers: a retrospective, matched cohort study. Br J Clin Pharmacol 2017;83:653-63. [Ref.ID 101935]
4.Tiene citas relacionadas Cita con resumen
Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, Ford I, Cruickshank JK, Caulfield MJ, Salsbury J, Mackenzie I, Padmanabhan S, Brown MJ, for The British Hypertension Society's PATHWAY Studies Group. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet 2015;386:2059-68. [Ref.ID 99524]
5.Tiene citas relacionadas Cita con resumen
George J, Majeed W, Mackenzie IS, MacDonald TM, Wei L. Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control study. BMJ 2013;347:f6954. [Ref.ID 97235]
6. Cita con resumen
Mackenzie IS, Wei L, MacDonald TM. Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritis. Eur J Clin Pharmacol 2013;69:133-41. [Ref.ID 95002]
7.Enlace a cita original
Wei L, MacDonald TM, Mackenzie IS. Pioglitazone and bladder cancer: a propensity score matched cohort study. Br J Clin Pharmacol 2013;75:254-9. [Ref.ID 94662]
8. Cita con resumen
Preiss D, Tikkanen MJ, Welsh P, Ford I, Lovato LC, Elam MB, LaRosa JC, DeMicco DA, Colhoun HM, Goldenberg I, Murphy MJ, MacDonald TM, Pedersen TR, Keech AC, Ridker PM, Kjekshus J, Sattar N, McMurray JJV. Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA 2012;308:804-11. [Ref.ID 93611]
9. Cita con resumen
Mackenzie IS, MacDonald TM, Thompson A, Morant S, Wei L. Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study. BMJ 2012;345:17. [Ref.ID 93545]
10.Enlace a cita original
Mackenzie IS, MacDonald TM, Shakir S, Dryburgh M, Mantay BJ, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and prengnacy outcomes. Br J Clin Pharmacol 2012;73:801-11. [Ref.ID 92797]
11.Tiene citas relacionadas Cita con resumen
Wei L, MacDonald TM, Mackenzie IS. Co-prescription of co-trimoxazole and spironolactone in elderly patients. BMJ 2011;343:544-5. [Ref.ID 91467]
12.Tiene citas relacionadas
Brown M, McInnes GI, MacDonald TM, for the British Hypertension Society (BHS) Research Working Party. initial combination therapy for treatment of hypertension. Authors' reply. Lancet 2011;377:1492. [Ref.ID 90681]
14.Enlace a cita original Cita con resumen
Wei L, Struthers AD, Fahey T, Watson AD, MacDonald TM. Spironolactone use and renal toxicity: population based longitudinal analysis. BMJ 2010;340:1233. [Ref.ID 88639]
15.
MacDonald TM, Morant SV. Prevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United Kingdom. Br J Clin Pharmacol 2008;65:775-86. [Ref.ID 82753]
16.Enlace a cita original
Murphy MJ, Wei L, Watson AD, MacDonald TM. 'Real-life' reduction in cholesterol with statins, 1993 to 2002. Br J Clin Pharmacol 2008;65:587-92. [Ref.ID 82508]
17.Tiene citas relacionadas
MacDonald TM. Acetaminophen: risk-management urgently required. Pharmacoepidemiol Drug Saf 2006;15:406-9. [Ref.ID 77536]
18.Tiene citas relacionadas
Ebrahim S, Wei L, Davey PD, MacDonald TM, Sullivan FM. Secondary prevention of heart disease with statins. Authors' reply. BMJ 2005;330:1208-9. [Ref.ID 73876]
20. Cita con resumen
Wei L, Flynn R, Murray GD, MacDonald TM. Use and adherence to beta-blockers for secondary prevention of myocardial infarction: who is not getting the treatment?. Pharmacoepidemiol Drug Saf 2004;13:761-6. [Ref.ID 72046]
Seleccionar todas
 
 1 a 20 de 70 siguiente >>